Drug profile · INN
benzgalantamine gluconate
ZUNVEYL
benzgalantamine gluconate (ZUNVEYL) is a acetylcholinesterase inhibitor. Associated with COGNITION THERAPEUTICS INC. Route of administration: oral. Current US regulatory status: approved.
Drug details — benzgalantamine gluconate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 20
- Programs
- 4
- Data quality
- 0.89
Quick answer
benzgalantamine gluconate (ZUNVEYL) is a acetylcholinesterase inhibitor. Associated with COGNITION THERAPEUTICS INC. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Acetylcholinesterase inhibitor
Primary target: Acetylcholinesterase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12208167
Coated tablets for pH-dependent release of benzgalantamine
granted -
US 12157743
Solid forms of Alpha-1062 gluconate
granted -
US 12076377
Variant sulfatase enzymes with enhanced properties
granted -
US 11795176
Solid forms of Alpha-1062 gluconate
granted -
US 11154614
Method for producing virus like particles
granted -
US 11028153
Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins
granted -
US 10487140
Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins
granted -
US 10278977
Methods for treating hypersomnolence
granted -
US 10233450
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
granted -
US 10106792
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
granted -
US 9988630
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
granted -
US 9873875
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
granted -
US 9518262
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
granted -
US 9441227
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
granted -
US 9365849
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
granted -
US 9200028
Steroids having increased water solubility and resistance against metabolism and methods for their production
granted -
US 8883996
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
granted -
US 8809515
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
granted -
US 8796444
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
granted -
US 8691786
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
granted
Frequently asked questions
What is benzgalantamine gluconate?
benzgalantamine gluconate (ZUNVEYL) is a acetylcholinesterase inhibitor. Associated with COGNITION THERAPEUTICS INC. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for benzgalantamine gluconate?
ZUNVEYL is a marketed brand name for benzgalantamine gluconate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of benzgalantamine gluconate?
benzgalantamine gluconate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.